Predict your next investment

Venture Capital
rockportcap.com

See what CB Insights has to offer

Investments

158

Portfolio Exits

34

Funds

4

Partners & Customers

1

Service Providers

1

About RockPort Capital Partners

Rockport Capital is a venture capital firm that specializes in the Cleantech industry. Within cleantech, they invest in five primary segments: (1) energy & power, (2) resource efficiency, (3) transportation, (4) advanced materials and (5) green Building. Rockport invests in companies at all stages of development, from seed stage to companies with substantial commercial revenues. Depending on stage and risk profile, Rockport may invest between $500,000 and $25 million in a round or company. Rockport typically seeks significant ownership in return for their invested capital and often lead the initial round in which they participate.

RockPort Capital Partners Headquarter Location

160 Federal Street 18th floor

Boston, Massachusetts, 02110,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest RockPort Capital Partners News

BREAKING: NewLeaf Raises $24m Series C, Doubling Funding for Next Gen Biologicals

Jul 10, 2017

NewLeaf Symbiotics, a biological crop input startup based in St Louis, has closed a $24 million Series C round led by Monsanto Growth Ventures (MGV) and Otter Capital . Lewis & Clark Ventures also participated along with Rockport Capital Partners , Pangaea Ventures , Open Prairie Ventures , and others. The company will use the funds to triple the size of its R&D team and increase its facility to 16,000 sq ft. It will also build a fermentation pilot facility for product development purposes and get its beneficial bacteria-based products (commonly referred to as “biologicals”) to market. NewLeaf’s first product will come to market at the end of 2017 or beginning of 2018 for use in the 2018 planting season, Tom Laurita, CEO told AgFunderNews. The product will initially be formulated for soybeans, peanuts, corn, wheat and tomatoes. The company has been focused exclusively on Pink Pigmented Facultative Methylotrophs (PPFM) bacteria since its founding in 2012. This beneficial bacteria is present on all plant life and is able to convert plant waste compounds into beneficial nutrients, boosting plant health and yield. Laurita equated his biological product to probiotic products for humans. Distribution of the product will focus on the US, Canada, and Argentina, where NewLeaf has been successfully piloting the product for three years. The company holds patents in the US, Europe, and Japan. Laurita said that much of the biologicals research going on in the industry is unfocused, throwing many different microbes at a common problem to see if something works. “We know that this type of bacteria has many different functions so we’re going to become experts at that rather than do a survey.” Laurita said that the shaky reputation of biologicals to date is part of what caused them to delay bringing their product to market until it had been sufficiently tested with proven success. Though he admits that the entire field has taken a step forward in recent years. “When we started six years ago, the question of how they work was an open question. I think we’re on the next generation of biologicals at this point,” said Laurita. “There have been a lot of snake oil products out there. The wave of everybody and his cousin selling something, I think, is over.” Biologicals can get to market quickly as most escape EPA review. Laurita explained that since PPFM are naturally present in plant life, the EPA only requires registration if a pesticidal claim is being made. NewLeaf’s first two products will not require such a review, but he said the company will be filing for EPA registration for products with pesticidal applications this year. Review takes approximately two years. While biologicals have had a mixed reputation in the past, the big agricultural input players have staked large amounts of capital on their importance as future alternatives, or at least supplements, to conventional, synthetic agrochemicals. For instance, Bayer acquired biologicals startup AgraQuest in 2012 for $425 million and in the aftermath, established a dedicated office for its biologicals group in West Sacramento, CA. German chemical company BASF also made a move in the same direction, acquiring biological seed treatment company Becker Underwood in the same year for $1 billion. Koch Agronomic Services acquired the biological research and development business of Mendel Biotechnology in 2014. Laurita said that he is not looking to rid agriculture of synthetic chemicals as a lot of media coverage of biologicals has indicated. “One of the keys from our point of view is to recognize the place of biologicals in that larger universe. That has been in our DNA from the beginning. We’re not missionaries. The goal is not to change how agriculture works. Let’s understand how it works and understand where biologicals really fit,” a philosophy that jives with their lead investor Monsanto. “Our investors are quite patient and quite involved,” he said. NewLeaf’s strong ties to Monsanto are also deeper than just funding. Last year it hired a Monsanto microbiologist as vice president of research and development. A Monsanto district sales manager also joined NewLeaf as manager of field biology and agronomy last year. Ryan Rakestraw, MGV’s venture principal, said: “The application of these bacteria in agriculture has tremendous potential to enhance yields and improve plant health.” Before this round, NewLeaf raised $24 million in two equity rounds with an additional $3.55 million in debt financing, according to CrunchBase . Related Stories

RockPort Capital Partners Investments

158 Investments

RockPort Capital Partners has made 158 investments. Their latest investment was in Qnovo as part of their Series C on January 1, 2022.

CBI Logo

RockPort Capital Partners Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/12/2022

Series C

Qnovo

$24M

No

6

12/1/2020

Series D - II

NewLeaf Symbiotics

$22M

No

2

2/24/2020

Series D

NewLeaf Symbiotics

$20M

No

2

7/23/2019

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

7/10/2017

Series C

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/12/2022

12/1/2020

2/24/2020

7/23/2019

7/10/2017

Round

Series C

Series D - II

Series D

Seed VC

Series C

Company

Qnovo

NewLeaf Symbiotics

NewLeaf Symbiotics

Subscribe to see more

Subscribe to see more

Amount

$24M

$22M

$20M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

2

2

10

10

RockPort Capital Partners Portfolio Exits

34 Portfolio Exits

RockPort Capital Partners has 34 portfolio exits. Their latest portfolio exit was Broncus Medical on September 24, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/24/2021

IPO

$99M

Public

2

7/15/2021

Reverse Merger

$99M

2

11/18/2020

Acquired

$99M

8

7/16/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/17/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/24/2021

7/15/2021

11/18/2020

7/16/2019

6/17/2019

Exit

IPO

Reverse Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

2

2

8

10

10

RockPort Capital Partners Acquisitions

1 Acquisition

RockPort Capital Partners acquired 1 company. Their latest acquisition was Northern Power Systems on December 18, 2003.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/18/2003

Other

$99M

$11.3M

Acq - Fin

Date

12/18/2003

Investment Stage

Other

Companies

Valuation

$99M

Total Funding

$11.3M

Note

Acq - Fin

Sources

RockPort Capital Partners Fund History

4 Fund Histories

RockPort Capital Partners has 4 funds, including Rockport Capital Partners III LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/5/2008

Rockport Capital Partners III LP

Multi-Stage Venture Capital

Closed

$453M

1

1/19/2006

Rockport Capital Partners II LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/2003

RPCO Investment Fund I LP

Subscribe to see more

Subscribe to see more

$99M

10

1/1/2001

RockPort Capital Partners LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/5/2008

1/19/2006

12/31/2003

1/1/2001

Fund

Rockport Capital Partners III LP

Rockport Capital Partners II LP

RPCO Investment Fund I LP

RockPort Capital Partners LP

Fund Type

Multi-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$453M

$99M

$99M

$99M

Sources

1

10

10

10

RockPort Capital Partners Partners & Customers

1 Partners and customers

RockPort Capital Partners has 1 strategic partners and customers. RockPort Capital Partners recently partnered with General Electric on July 7, 2010.

Date

Type

Business Partner

Country

News Snippet

Sources

7/14/2010

Partner

United States

RockPort Capital Partners » In the News

RockPort joins leading VC firms Foundation Capital , Kleiner Perkins Caufield & Byer , and Emerald Technology Ventures to partner with GE .

1

Date

7/14/2010

Type

Partner

Business Partner

Country

United States

News Snippet

RockPort Capital Partners » In the News

RockPort joins leading VC firms Foundation Capital , Kleiner Perkins Caufield & Byer , and Emerald Technology Ventures to partner with GE .

Sources

1

RockPort Capital Partners Service Providers

1 Service Provider

RockPort Capital Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

RockPort Capital Partners Team

8 Team Members

RockPort Capital Partners has 8 team members, including current Chief Operating Officer, Janet James.

Name

Work History

Title

Status

Janet James

Chief Operating Officer

Current

David Prend

Chief Operating Officer

Current

William E. James

General Partner

Current

Charles J. Mcdermott

General Partner

Current

Stoddard Moran Wilson

General Partner

Current

Name

Janet James

David Prend

William E. James

Charles J. Mcdermott

Stoddard Moran Wilson

Work History

Title

Chief Operating Officer

Chief Operating Officer

General Partner

General Partner

General Partner

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.